JP2010513279A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513279A5 JP2010513279A5 JP2009541375A JP2009541375A JP2010513279A5 JP 2010513279 A5 JP2010513279 A5 JP 2010513279A5 JP 2009541375 A JP2009541375 A JP 2009541375A JP 2009541375 A JP2009541375 A JP 2009541375A JP 2010513279 A5 JP2010513279 A5 JP 2010513279A5
- Authority
- JP
- Japan
- Prior art keywords
- medical
- subject
- adjuvant
- ribose
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000240 adjuvant Effects 0.000 claims 6
- 239000002671 adjuvant Substances 0.000 claims 6
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 6
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 230000002685 pulmonary Effects 0.000 claims 2
- 208000006673 Asthma Diseases 0.000 claims 1
- 206010006451 Bronchitis Diseases 0.000 claims 1
- 206010072082 Environmental exposure Diseases 0.000 claims 1
- 208000008425 Protein Deficiency Diseases 0.000 claims 1
- 231100000765 Toxin Toxicity 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000003883 cystic fibrosis Diseases 0.000 claims 1
- 230000004199 lung function Effects 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 230000000391 smoking Effects 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 108020003112 toxins Proteins 0.000 claims 1
Claims (5)
- 不十分な肺機能を有するが、心合併症を患っていない被験体の不十分な肺機能を治療するためのDリボースを含む医療用補助薬であって、前記Dリボースが1日に1回から4回、2から10グラムの量で前記被験体に慢性投与されることを特徴とする、医療用補助薬。
- 前記医療用補助薬が3から5グラムの前記Dリボースを含み、前記医療用補助薬が1日に3回もしくは4回、前記被験体に投与されることを特徴とする、請求項1の医療用補助薬。
- 前記医療用補助薬が、1日に1回から4回、少なくとも1か月の間、前記被験体に投与されることを特徴とする、請求項1の医療用補助薬。
- 不十分な肺機能を有する前記被験体が、慢性閉塞性肺疾患を患うことを特徴とする、請求項1の医療用補助薬。
- 不十分な肺機能を有する前記被験体が、気管支炎、喫煙、喘息、アルファ‐1抗トリプシノゲンの遺伝子欠損、有機溶媒もしくは毒素に工業暴露または環境暴露されること、あるいは嚢胞性線維症、に起因する慢性閉塞性肺疾患の危険性があることを特徴とする、請求項1の医療用補助薬。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/639,476 US20100099630A1 (en) | 2004-04-29 | 2006-12-15 | Method for improving ventilatory efficiency |
PCT/US2007/025478 WO2008076296A2 (en) | 2006-12-15 | 2007-12-13 | D-ribose for treating suboptimal pulmonary function |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010513279A JP2010513279A (ja) | 2010-04-30 |
JP2010513279A5 true JP2010513279A5 (ja) | 2011-03-17 |
Family
ID=39536891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009541375A Pending JP2010513279A (ja) | 2006-12-15 | 2007-12-13 | 不十分な肺機能を処置するためのd−リボース |
Country Status (7)
Country | Link |
---|---|
US (1) | US20100099630A1 (ja) |
EP (1) | EP2101788A2 (ja) |
JP (1) | JP2010513279A (ja) |
CN (1) | CN101657202A (ja) |
BR (1) | BRPI0718356A2 (ja) |
CA (1) | CA2672257A1 (ja) |
WO (1) | WO2008076296A2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5396387B2 (ja) * | 2007-01-23 | 2014-01-22 | バイオエナジー インコーポレイティド | 心臓不整脈を治療するためのd−リボースの用途 |
CA2734769A1 (en) * | 2008-08-20 | 2010-02-25 | Bioenergy, Inc. | Use of d-ribose for fatigued subjects |
KR20170082568A (ko) * | 2014-11-03 | 2017-07-14 | 바이오에너지 라이프 사이언스, 인코포레이티드 | 신체적 스트레스에 대한 순응을 증진시키기 위한 d-리보오스의 용도 |
EP3411041A1 (en) | 2016-02-01 | 2018-12-12 | RiboCor, Inc. | Use of ribose for treatment of subjects having congestive heart failure |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4767785A (en) * | 1984-01-18 | 1988-08-30 | Michael Georgieff | Hypocaloric preparation and intravenous method for hypocaloric treatment of patients |
US4605644A (en) * | 1985-02-07 | 1986-08-12 | Regents Of The University Of Minnesota | Method for stimulating recovery from ischemia employing ribose and adenine |
US4719201A (en) * | 1985-02-07 | 1988-01-12 | Regents Of The University Of Minnesota | Method for stimulating recovery from ischemia |
US4824660A (en) * | 1985-06-06 | 1989-04-25 | Paul S. Angello | Method of determining the viability of tissue in an organism |
US5140045A (en) * | 1989-11-30 | 1992-08-18 | Clintec Nutrition Co. | Method for improving ventilation during sleep and treating sleep related ventilation abnormalities of neonates |
EP0517573A1 (fr) * | 1991-06-05 | 1992-12-09 | Synthelabo | Compositions pharmaceutiques pour le traitement des affections des voies respiratoires |
US5874420A (en) * | 1995-12-26 | 1999-02-23 | Allegheny University Of The Health Sciences | Process for regulating vagal tone |
US5719196A (en) * | 1996-07-24 | 1998-02-17 | Leiras Oy | Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol |
GB9715340D0 (en) * | 1997-07-22 | 1997-09-24 | Cerestar Holding Bv | Beverages for enhanced physical performance |
US6054143A (en) * | 1998-03-24 | 2000-04-25 | Jones; Alonzo H. | Xylitol delivery |
US6159942A (en) * | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
US6218366B1 (en) * | 1998-06-19 | 2001-04-17 | Bioenergy, Inc. | Method for raising the hypoxic threshold |
US6926911B1 (en) * | 1998-12-22 | 2005-08-09 | The University Of North Carolina At Chapel Hill | Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
EP2258183A1 (en) * | 1998-12-22 | 2010-12-08 | The University of North Carolina at Chapel Hill | Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs |
US6429198B1 (en) * | 1999-04-12 | 2002-08-06 | Bioenergy Inc. | Compositions for increasing athletic performance in mammals |
US20020119933A1 (en) * | 2000-07-28 | 2002-08-29 | Butler Terri L. | Compositions and methods for improving cardiovascular function |
US6534480B2 (en) * | 1999-06-17 | 2003-03-18 | Bioenergy Inc. | Compositions for increasing energy in vivo |
US6159943A (en) * | 1999-09-24 | 2000-12-12 | Bioenergy, Inc. | Use of ribose to prevent cramping and soreness in muscles |
US6339716B1 (en) * | 1999-09-24 | 2002-01-15 | Bioenergy Inc. | Method for determining viability of a myocardial segment |
US6511964B2 (en) * | 1999-09-24 | 2003-01-28 | Bioenergy, Inc. | Method for treating acute mountain sickness |
US6703370B1 (en) * | 1999-10-27 | 2004-03-09 | Bioenergy, Inc. | Use of ribose to treat fibromyalgia |
EP1244353B1 (en) * | 1999-12-21 | 2004-11-17 | Viacell, LLC | Compositions for the storage of platelets |
EP1282424A1 (en) * | 2000-01-07 | 2003-02-12 | Bioenergy Inc. | compositions for enhancing the immune response |
WO2001052831A1 (en) * | 2000-01-20 | 2001-07-26 | Bioenergy Inc. | Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans |
US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
EP1247525A1 (en) * | 2001-04-02 | 2002-10-09 | Bioenergy Inc. | Use of a monosaccharide in the manufacture of a medicament against acute mountain sickness |
US20030212006A1 (en) * | 2002-05-13 | 2003-11-13 | Seifert John G. | Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals |
US8486859B2 (en) * | 2002-05-15 | 2013-07-16 | Bioenergy, Inc. | Use of ribose to enhance plant growth |
US8759315B2 (en) * | 2003-05-14 | 2014-06-24 | Viacell, Llc | Methods for rejuvenating |
US7687468B2 (en) * | 2003-05-14 | 2010-03-30 | Viacell, LLC. | Rejuvenation of stored blood |
US20040229205A1 (en) * | 2003-05-16 | 2004-11-18 | Ericson Daniel G. | Compositions for the storage of platelets |
US20070105787A1 (en) * | 2004-01-14 | 2007-05-10 | St Cyr John A | Use of ribose in recovery from anaesthesia |
ES2393786T3 (es) * | 2004-04-29 | 2012-12-28 | Ribocor, Inc. | Método para mejorar la eficacia ventilatoria |
US8835396B2 (en) * | 2006-12-15 | 2014-09-16 | Bioenergy, Inc. | Method and compositions for improving pulmonary hypertension |
US20080312169A1 (en) * | 2007-03-20 | 2008-12-18 | Clarence Albert Johnson | Cosmetic use of D-ribose |
-
2006
- 2006-12-15 US US11/639,476 patent/US20100099630A1/en not_active Abandoned
-
2007
- 2007-12-13 WO PCT/US2007/025478 patent/WO2008076296A2/en active Application Filing
- 2007-12-13 JP JP2009541375A patent/JP2010513279A/ja active Pending
- 2007-12-13 CA CA002672257A patent/CA2672257A1/en not_active Abandoned
- 2007-12-13 BR BRPI0718356-9A patent/BRPI0718356A2/pt not_active IP Right Cessation
- 2007-12-13 EP EP07862846A patent/EP2101788A2/en not_active Withdrawn
- 2007-12-13 CN CN200780048757A patent/CN101657202A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009513660A5 (ja) | ||
JP2010513279A5 (ja) | ||
WO2007091266A3 (en) | Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases | |
JP2008535798A5 (ja) | ||
JP2010518061A5 (ja) | ||
CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
WO2008063581A3 (en) | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs | |
JP2010525055A5 (ja) | ||
NO20072920L (no) | Kombinasjon av metylxantinforbindelser og steroider for a behandle kroniske respirasjonssykdommer | |
WO2006108643A3 (en) | Organic compounds | |
WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
IL193099A (en) | Use of ferric citrate-containing preparations in the preparation of chronic kidney disease drugs | |
JP2006348039A5 (ja) | ||
JP2014507482A5 (ja) | ||
JP2007514637A5 (ja) | ||
JP2007314517A5 (ja) | ||
WO2009112274A3 (en) | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease | |
JP2006305390A5 (ja) | ||
NO20074084L (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse | |
NO20081480L (no) | Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma | |
JP2008526936A5 (ja) | ||
JP2008513426A5 (ja) | ||
JP2008519810A5 (ja) | ||
JP2005523263A5 (ja) | ||
JP2008513427A5 (ja) |